Dezima Pharma
closedDevelops drugs to treat dyslipidemic patients suffering from cardiovascular diseases.
Launch date
–
Market cap
-
Enterprise valuation
AUD464m (Public information from Mar 2017)
Company register number 55971946
Naarden North Holland (HQ)